Genetic Determinants of Neurobehavioral Responses to Caffeine Administration during Sleep Deprivation: A Randomized, Cross Over Study (NCT03859882)

This study investigated whether four single nucleotide polymorphisms (SNPs) moderated caffeine effects on vigilance and performance in a double-blind and crossover total sleep deprivation (TSD) protocol in 37 subjects. In caffeine (2 × 2.5 mg/kg/24 h) or placebo-controlled condition, subjects perfor...

Full description

Bibliographic Details
Main Authors: Mégane Erblang, Fabien Sauvet, Catherine Drogou, Michaël Quiquempoix, Pascal Van Beers, Mathias Guillard, Arnaud Rabat, Aurélie Trignol, Cyprien Bourrilhon, Marie-Claire Erkel, Damien Léger, Claire Thomas, Danielle Gomez-Merino, Mounir Chennaoui
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Genes
Subjects:
Online Access:https://www.mdpi.com/2073-4425/12/4/555
_version_ 1797538132086751232
author Mégane Erblang
Fabien Sauvet
Catherine Drogou
Michaël Quiquempoix
Pascal Van Beers
Mathias Guillard
Arnaud Rabat
Aurélie Trignol
Cyprien Bourrilhon
Marie-Claire Erkel
Damien Léger
Claire Thomas
Danielle Gomez-Merino
Mounir Chennaoui
author_facet Mégane Erblang
Fabien Sauvet
Catherine Drogou
Michaël Quiquempoix
Pascal Van Beers
Mathias Guillard
Arnaud Rabat
Aurélie Trignol
Cyprien Bourrilhon
Marie-Claire Erkel
Damien Léger
Claire Thomas
Danielle Gomez-Merino
Mounir Chennaoui
author_sort Mégane Erblang
collection DOAJ
description This study investigated whether four single nucleotide polymorphisms (SNPs) moderated caffeine effects on vigilance and performance in a double-blind and crossover total sleep deprivation (TSD) protocol in 37 subjects. In caffeine (2 × 2.5 mg/kg/24 h) or placebo-controlled condition, subjects performed a psychomotor vigilance test (PVT) and reported sleepiness every six hours (Karolinska sleepiness scale (KSS)) during TSD. EEG was also analyzed during the 09:15 PVT. Carriers of the TNF-α SNP A allele appear to be more sensitive than homozygote G/G genotype to an attenuating effect of caffeine on PVT lapses during sleep deprivation only because they seem more degraded, but they do not perform better as a result. The A allele carriers of COMT were also more degraded and sensitive to caffeine than G/G genotype after 20 h of sleep deprivation, but not after 26 and 32 h. Regarding PVT reaction time, ADORA2A influences the TSD effect but not caffeine, and PER3 modulates only the caffeine effect. Higher EEG theta activity related to sleep deprivation was observed in mutated TNF-α, PER3, and COMT carriers, in the placebo condition particularly. In conclusion, there are genetic influences on neurobehavioral impairments related to TSD that appear to be attenuated by caffeine administration. (NCT03859882).
first_indexed 2024-03-10T12:26:10Z
format Article
id doaj.art-800ecd5d92c34765aabbe201ff8053b2
institution Directory Open Access Journal
issn 2073-4425
language English
last_indexed 2024-03-10T12:26:10Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Genes
spelling doaj.art-800ecd5d92c34765aabbe201ff8053b22023-11-21T15:02:04ZengMDPI AGGenes2073-44252021-04-0112455510.3390/genes12040555Genetic Determinants of Neurobehavioral Responses to Caffeine Administration during Sleep Deprivation: A Randomized, Cross Over Study (NCT03859882)Mégane Erblang0Fabien Sauvet1Catherine Drogou2Michaël Quiquempoix3Pascal Van Beers4Mathias Guillard5Arnaud Rabat6Aurélie Trignol7Cyprien Bourrilhon8Marie-Claire Erkel9Damien Léger10Claire Thomas11Danielle Gomez-Merino12Mounir Chennaoui13Institut de Recherche Biomédicale des Armées (IRBA), 91190 Brétigny sur Orge, FranceInstitut de Recherche Biomédicale des Armées (IRBA), 91190 Brétigny sur Orge, FranceInstitut de Recherche Biomédicale des Armées (IRBA), 91190 Brétigny sur Orge, FranceInstitut de Recherche Biomédicale des Armées (IRBA), 91190 Brétigny sur Orge, FranceInstitut de Recherche Biomédicale des Armées (IRBA), 91190 Brétigny sur Orge, FranceInstitut de Recherche Biomédicale des Armées (IRBA), 91190 Brétigny sur Orge, FranceInstitut de Recherche Biomédicale des Armées (IRBA), 91190 Brétigny sur Orge, FranceInstitut de Recherche Biomédicale des Armées (IRBA), 91190 Brétigny sur Orge, FranceInstitut de Recherche Biomédicale des Armées (IRBA), 91190 Brétigny sur Orge, FranceInstitut de Recherche Biomédicale des Armées (IRBA), 91190 Brétigny sur Orge, FranceEA VIFASOM (EA 7330 Vigilance, Fatigue, Sommeil et Santé Publique), Université de Paris, 75004 Paris, FranceLBEPS, Univ Evry, IRBA, Université Paris Saclay, 91025 Evry, FranceInstitut de Recherche Biomédicale des Armées (IRBA), 91190 Brétigny sur Orge, FranceInstitut de Recherche Biomédicale des Armées (IRBA), 91190 Brétigny sur Orge, FranceThis study investigated whether four single nucleotide polymorphisms (SNPs) moderated caffeine effects on vigilance and performance in a double-blind and crossover total sleep deprivation (TSD) protocol in 37 subjects. In caffeine (2 × 2.5 mg/kg/24 h) or placebo-controlled condition, subjects performed a psychomotor vigilance test (PVT) and reported sleepiness every six hours (Karolinska sleepiness scale (KSS)) during TSD. EEG was also analyzed during the 09:15 PVT. Carriers of the TNF-α SNP A allele appear to be more sensitive than homozygote G/G genotype to an attenuating effect of caffeine on PVT lapses during sleep deprivation only because they seem more degraded, but they do not perform better as a result. The A allele carriers of COMT were also more degraded and sensitive to caffeine than G/G genotype after 20 h of sleep deprivation, but not after 26 and 32 h. Regarding PVT reaction time, ADORA2A influences the TSD effect but not caffeine, and PER3 modulates only the caffeine effect. Higher EEG theta activity related to sleep deprivation was observed in mutated TNF-α, PER3, and COMT carriers, in the placebo condition particularly. In conclusion, there are genetic influences on neurobehavioral impairments related to TSD that appear to be attenuated by caffeine administration. (NCT03859882).https://www.mdpi.com/2073-4425/12/4/555geneticscaffeinetotal sleep deprivationPVTpro-inflammatory cytokineadenosine
spellingShingle Mégane Erblang
Fabien Sauvet
Catherine Drogou
Michaël Quiquempoix
Pascal Van Beers
Mathias Guillard
Arnaud Rabat
Aurélie Trignol
Cyprien Bourrilhon
Marie-Claire Erkel
Damien Léger
Claire Thomas
Danielle Gomez-Merino
Mounir Chennaoui
Genetic Determinants of Neurobehavioral Responses to Caffeine Administration during Sleep Deprivation: A Randomized, Cross Over Study (NCT03859882)
Genes
genetics
caffeine
total sleep deprivation
PVT
pro-inflammatory cytokine
adenosine
title Genetic Determinants of Neurobehavioral Responses to Caffeine Administration during Sleep Deprivation: A Randomized, Cross Over Study (NCT03859882)
title_full Genetic Determinants of Neurobehavioral Responses to Caffeine Administration during Sleep Deprivation: A Randomized, Cross Over Study (NCT03859882)
title_fullStr Genetic Determinants of Neurobehavioral Responses to Caffeine Administration during Sleep Deprivation: A Randomized, Cross Over Study (NCT03859882)
title_full_unstemmed Genetic Determinants of Neurobehavioral Responses to Caffeine Administration during Sleep Deprivation: A Randomized, Cross Over Study (NCT03859882)
title_short Genetic Determinants of Neurobehavioral Responses to Caffeine Administration during Sleep Deprivation: A Randomized, Cross Over Study (NCT03859882)
title_sort genetic determinants of neurobehavioral responses to caffeine administration during sleep deprivation a randomized cross over study nct03859882
topic genetics
caffeine
total sleep deprivation
PVT
pro-inflammatory cytokine
adenosine
url https://www.mdpi.com/2073-4425/12/4/555
work_keys_str_mv AT meganeerblang geneticdeterminantsofneurobehavioralresponsestocaffeineadministrationduringsleepdeprivationarandomizedcrossoverstudynct03859882
AT fabiensauvet geneticdeterminantsofneurobehavioralresponsestocaffeineadministrationduringsleepdeprivationarandomizedcrossoverstudynct03859882
AT catherinedrogou geneticdeterminantsofneurobehavioralresponsestocaffeineadministrationduringsleepdeprivationarandomizedcrossoverstudynct03859882
AT michaelquiquempoix geneticdeterminantsofneurobehavioralresponsestocaffeineadministrationduringsleepdeprivationarandomizedcrossoverstudynct03859882
AT pascalvanbeers geneticdeterminantsofneurobehavioralresponsestocaffeineadministrationduringsleepdeprivationarandomizedcrossoverstudynct03859882
AT mathiasguillard geneticdeterminantsofneurobehavioralresponsestocaffeineadministrationduringsleepdeprivationarandomizedcrossoverstudynct03859882
AT arnaudrabat geneticdeterminantsofneurobehavioralresponsestocaffeineadministrationduringsleepdeprivationarandomizedcrossoverstudynct03859882
AT aurelietrignol geneticdeterminantsofneurobehavioralresponsestocaffeineadministrationduringsleepdeprivationarandomizedcrossoverstudynct03859882
AT cyprienbourrilhon geneticdeterminantsofneurobehavioralresponsestocaffeineadministrationduringsleepdeprivationarandomizedcrossoverstudynct03859882
AT marieclaireerkel geneticdeterminantsofneurobehavioralresponsestocaffeineadministrationduringsleepdeprivationarandomizedcrossoverstudynct03859882
AT damienleger geneticdeterminantsofneurobehavioralresponsestocaffeineadministrationduringsleepdeprivationarandomizedcrossoverstudynct03859882
AT clairethomas geneticdeterminantsofneurobehavioralresponsestocaffeineadministrationduringsleepdeprivationarandomizedcrossoverstudynct03859882
AT daniellegomezmerino geneticdeterminantsofneurobehavioralresponsestocaffeineadministrationduringsleepdeprivationarandomizedcrossoverstudynct03859882
AT mounirchennaoui geneticdeterminantsofneurobehavioralresponsestocaffeineadministrationduringsleepdeprivationarandomizedcrossoverstudynct03859882